The difference in TIMP3 expression after PROX1 silencing in CGTH-W-1 and FTC-133 is probably a result of opposing regulation and variable baseline expression of MMPs and their inhibitors in cell lines derived from thyroid carcinomas [33]. This evidence concerns the gene TIMP3 and thyroid gland carcinoma.